Xin Chen, Mingli Gu, Tengda Li, Yi Sun
Journal: Future microbiology 2021;16():577-588
PMID: 33973485
To understand the pathological progress of COVID-19 and to explore the potential biomarkers. The COVID-19 pandemic is ongoing. There is metabolomics research about COVID-19 indicating the rich information of metabolomics is worthy of further data mining. We applied bioinformatics technology to reanalyze the published metabolomics data of COVID-19. Benzoate, β-alanine and 4-chlorobenzoic acid were first reported to be used as potential biomarkers to distinguish COVID-19 patients from healthy individuals; taurochenodeoxycholic acid 3-sulfate, glucuronate and N,N,N-trimethyl-alanylproline betaine TMAP are the top classifiers in the receiver operating characteristic curve of COVID-severe and COVID-nonsevere patients. These unique metabolites suggest an underlying immunoregulatory treatment strategy for COVID-19.
Full Text Sources:
Medical:
Other Literature Sources:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.